ALLOVIR - Trademark Details
Status: 732 - Third Extension - Granted
Image for trademark with serial number 88381011
Serial Number
88381011
Word Mark
ALLOVIR
Status
732 - Third Extension - Granted
Status Date
2021-10-19
Filing Date
2019-04-11
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2020-02-25
Attorney Name
Maury M. Tepper, III
Law Office Assigned Location Code
N50
Employee Name
DESJARDINS, RACHEL EVE
Statements
Goods and Services
Anti-cancer preparations; Anti-infectives; Biological preparations for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer, namely, gastrointestinal diseases, pulmonary hypertension, musculo-skeletal disorders, and auto-immune disorders; Biological preparations for the treatment of cancer; Medical preparations for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer, namely, gastrointestinal diseases, pulmonary hypertension, musculo-skeletal disorders, and auto-immune disorders; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer, namely, gastrointestinal diseases, pulmonary hypertension, musculo-skeletal disorders, and auto-immune disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer, namely, gastrointestinal diseases, pulmonary hypertension, musculo-skeletal disorders, and auto-immune disorders; Vaccines against pneumococcal infections
Pseudo Mark
ALLOVER
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-04-29
Primary Code
005
Current Trademark Owners
Party Name
ALLOVIR, INC.
Party Type
21 - 1st New Owner After Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
ALLOVIR, INC.
Party Type
21 - 1st New Owner After Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
ViraCyte Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
ViraCyte Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Maury M. Tepper, III
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2019-04-15NEW APPLICATION ENTERED IN TRAM
2019-04-29NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-06-21ASSIGNED TO EXAMINER
2019-06-22NON-FINAL ACTION WRITTEN
2019-06-22NON-FINAL ACTION E-MAILED
2019-06-22NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-01-03ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
2020-01-03ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
2020-01-04TEAS PETITION TO REVIVE RECEIVED
2020-01-04PETITION TO REVIVE-GRANTED
2020-01-04TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-01-06NOTICE OF REVIVAL - E-MAILED
2020-01-17ASSIGNED TO LIE
2020-01-17CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-01-17TEAS/EMAIL CORRESPONDENCE ENTERED
2020-01-18APPROVED FOR PUB - PRINCIPAL REGISTER
2020-02-05NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-02-25PUBLISHED FOR OPPOSITION
2020-02-25OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-04-21NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-05-27AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2020-11-23ABANDONMENT - NO USE STATEMENT FILED
2020-11-23ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
2020-11-23TEAS PETITION TO REVIVE RECEIVED
2020-11-23PETITION TO REVIVE-GRANTED
2020-11-23EXTENSION RECEIVED WITH TEAS PETITION
2020-11-24NOTICE OF REVIVAL - E-MAILED
2021-02-22CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-10-21EXTENSION 1 FILED
2021-02-23EXTENSION 1 GRANTED
2021-02-24NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-05-24ABANDONMENT - NO USE STATEMENT FILED
2021-05-24ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
2021-05-24TEAS PETITION TO REVIVE RECEIVED
2021-05-24PETITION TO REVIVE-GRANTED
2021-05-24EXTENSION RECEIVED WITH TEAS PETITION
2021-05-25NOTICE OF REVIVAL - E-MAILED
2021-04-21EXTENSION 2 FILED
2021-05-28EXTENSION 2 GRANTED
2021-05-29NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-06-10TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-06-10ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-06-10TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-10-19TEAS EXTENSION RECEIVED
2021-10-19EXTENSION 3 FILED
2021-10-19EXTENSION 3 GRANTED
2021-10-21NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED